seems as if both sides are very stupid
No bankruptcy on account of the raised capital yet the to-go brand model is clearly flawed. This company needs to become a actual biotech company and focus on it's drugs. If they ever get their excellegan to sell and use that money to actually move generex. Than and only then will this company be a buy but until that day occurs, its a hold.
Sentiment: Hold